Cardiac amyloidosis.

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Cardiac amyloidosis should be considered in a patient with heart failure, who is normotensive with decreased left ventricular systolic function and marked left ventricular hypertrophy by echocardiogram and has decreased voltage by ECG. Furthermore, when the diagnosis of cardiac amyloid is made, it is important to classify the subtype of disease to be able to offer appropriate treatment. Contrary to traditional belief that the prognosis for patients with amyloidosis is dismal, some forms of this disease are curable and other forms are characterized by slow progression of disease.

Original languageEnglish (US)
Pages (from-to)201-206
Number of pages6
JournalJournal of the South Carolina Medical Association (1975)
Volume97
Issue number5
StatePublished - 2001
Externally publishedYes

Fingerprint

Amyloidosis
Left Ventricular Hypertrophy
Left Ventricular Function
Amyloid
Disease Progression
Electrocardiography
Heart Failure
Therapeutics

Cite this

Cardiac amyloidosis. / Kingman, A.; Pereira, Naveen Luke.

In: Journal of the South Carolina Medical Association (1975), Vol. 97, No. 5, 2001, p. 201-206.

Research output: Contribution to journalArticle

@article{775e20ff98c843b1986578ddd45de1b7,
title = "Cardiac amyloidosis.",
abstract = "Cardiac amyloidosis should be considered in a patient with heart failure, who is normotensive with decreased left ventricular systolic function and marked left ventricular hypertrophy by echocardiogram and has decreased voltage by ECG. Furthermore, when the diagnosis of cardiac amyloid is made, it is important to classify the subtype of disease to be able to offer appropriate treatment. Contrary to traditional belief that the prognosis for patients with amyloidosis is dismal, some forms of this disease are curable and other forms are characterized by slow progression of disease.",
author = "A. Kingman and Pereira, {Naveen Luke}",
year = "2001",
language = "English (US)",
volume = "97",
pages = "201--206",
journal = "The Journal of the South Carolina Medical Association",
issn = "0038-3139",
publisher = "South Carolina Medical Association",
number = "5",

}

TY - JOUR

T1 - Cardiac amyloidosis.

AU - Kingman, A.

AU - Pereira, Naveen Luke

PY - 2001

Y1 - 2001

N2 - Cardiac amyloidosis should be considered in a patient with heart failure, who is normotensive with decreased left ventricular systolic function and marked left ventricular hypertrophy by echocardiogram and has decreased voltage by ECG. Furthermore, when the diagnosis of cardiac amyloid is made, it is important to classify the subtype of disease to be able to offer appropriate treatment. Contrary to traditional belief that the prognosis for patients with amyloidosis is dismal, some forms of this disease are curable and other forms are characterized by slow progression of disease.

AB - Cardiac amyloidosis should be considered in a patient with heart failure, who is normotensive with decreased left ventricular systolic function and marked left ventricular hypertrophy by echocardiogram and has decreased voltage by ECG. Furthermore, when the diagnosis of cardiac amyloid is made, it is important to classify the subtype of disease to be able to offer appropriate treatment. Contrary to traditional belief that the prognosis for patients with amyloidosis is dismal, some forms of this disease are curable and other forms are characterized by slow progression of disease.

UR - http://www.scopus.com/inward/record.url?scp=0035351152&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035351152&partnerID=8YFLogxK

M3 - Article

C2 - 11381776

AN - SCOPUS:0035351152

VL - 97

SP - 201

EP - 206

JO - The Journal of the South Carolina Medical Association

JF - The Journal of the South Carolina Medical Association

SN - 0038-3139

IS - 5

ER -